- Home
- MAYA vs SCPH Comparison
MAYA vs SCPH Comparison
Compare MAYA & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAYA
- SCPH
- Stock Information
- Founded
- MAYA 2024
- SCPH 2013
- Country
- MAYA United States
- SCPH United States
- Employees
- MAYA N/A
- SCPH N/A
- Industry
- MAYA
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- MAYA
- SCPH Health Care
- Exchange
- MAYA NYSE
- SCPH Nasdaq
- Market Cap
- MAYA 149.9M
- SCPH 173.6M
- IPO Year
- MAYA 2025
- SCPH 2017
- Fundamental
- Price
- MAYA $10.07
- SCPH $4.25
- Analyst Decision
- MAYA
- SCPH Strong Buy
- Analyst Count
- MAYA 0
- SCPH 3
- Target Price
- MAYA N/A
- SCPH $14.00
- AVG Volume (30 Days)
- MAYA 526.0
- SCPH 486.9K
- Earning Date
- MAYA 01-01-0001
- SCPH 05-14-2025
- Dividend Yield
- MAYA N/A
- SCPH N/A
- EPS Growth
- MAYA N/A
- SCPH N/A
- EPS
- MAYA N/A
- SCPH N/A
- Revenue
- MAYA N/A
- SCPH $41,982,000.00
- Revenue This Year
- MAYA N/A
- SCPH $108.95
- Revenue Next Year
- MAYA N/A
- SCPH $73.83
- P/E Ratio
- MAYA N/A
- SCPH N/A
- Revenue Growth
- MAYA N/A
- SCPH 138.10
- 52 Week Low
- MAYA $10.03
- SCPH $1.94
- 52 Week High
- MAYA $10.65
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- MAYA N/A
- SCPH 75.54
- Support Level
- MAYA N/A
- SCPH $3.42
- Resistance Level
- MAYA N/A
- SCPH $4.36
- Average True Range (ATR)
- MAYA 0.00
- SCPH 0.25
- MACD
- MAYA 0.00
- SCPH 0.07
- Stochastic Oscillator
- MAYA 0.00
- SCPH 90.60
About MAYA MAYWOOD ACQUISITION CORP
Maywood Acquisition Corp is a blank check company.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.